Ysios Capital

Ysios Capital is a leading life sciences venture capital firm founded in 2008, with offices in San Sebastián and Barcelona, Spain. The firm specializes in financing highly innovative biotechnology companies worldwide, focusing on developing novel therapeutics for indications with high unmet medical needs.

Investment Focus:

Ysios Capital invests in early and mid-stage biotech, healthtech, medtech, pharma, and life sciences companies. The firm manages over €400 million in assets under management (AUM) through three dedicated funds in life sciences.

Portfolio Highlights:

Ysios Capital’s diverse portfolio features disruptive biotech ventures with exceptional teams and innovative science. Notable companies include:

CorWave: A French medtech company developing next-generation blood pumps for heart failure patients.

Vivet Therapeutics: A company focused on gene therapy for metabolic diseases.

These investments reflect Ysios Capital’s commitment to fostering innovation in the life sciences sector.

For more information about Ysios Capital and their investment strategies, you can visit their official website.